Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Jet2 cuts winter capacity and forecasts lower profit growth for 2026 amid a less certain consumer environment and ongoing challenges.
Russian man Vadim Kruglov found dead at Burning Man festival, investigation underway
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Jet2 cuts winter capacity and forecasts lower profit growth for 2026 amid a less certain consumer environment and ongoing challenges.
Russian man Vadim Kruglov found dead at Burning Man festival, investigation underway